00:49 , Feb 1, 2019 |  BC Week In Review  |  Financial News

Corbus raises $35M follow-on

Inflammatory and fibrotic diseases company Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) raised $35 million on Jan. 25 through the sale of 5.4 million shares at $6.50 in a follow-on underwritten by Jefferies, RBC, JMP, Oppenheimer and...
19:56 , Jul 13, 2018 |  BC Week In Review  |  Financial News

ArQule raises $69.6M follow-on

Cancer and rare disease company ArQule Inc. (NASDAQ:ARQL) raised $69.6 million through the sale of 12.7 million shares at $5.50 in a follow-on underwritten by Leerink, Needham, Roth Capital, B. Riley FBR and JonesTrading. The...
17:20 , Apr 13, 2018 |  BC Week In Review  |  Financial News

Novavax prices $50M follow-on

Infectious disease company Novavax Inc. (NASDAQ:NVAX) raised $50 million after hours on April 11 through the sale of 30.3 million shares at $1.65 in a follow-on underwritten by Citigroup, Piper Jaffray, Cantor Fitzgerald, Ladenburg Thalmann...
18:23 , Feb 16, 2018 |  BC Week In Review  |  Financial News

Catalyst raises $115M follow-on

Catalyst Biosciences Inc. (NASDAQ:CBIO) raised $115 million through the sale of 3.4 million shares at $34 in a follow-on underwritten by JonesTrading Institutional Services, Ladenburg Thalmann, LifeSci Capital and B. Riley FBR. The figures include...
22:28 , Feb 13, 2018 |  BC Extra  |  Financial News

Catalyst prices $100M follow-on

Catalyst Biosciences Inc. (NASDAQ:CBIO) raised $100 million through the sale of 2.9 million shares at $34 in a follow-on underwritten by JonesTrading Institutional Services, Ladenburg Thalmann, LifeSci Capital and B. Riley FBR. The price is...
16:26 , Jan 26, 2018 |  BC Week In Review  |  Financial News

Arrowhead raises $60.4M follow-on

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) raised $60.4 million through the sale of 11.5 million shares at $5.25 in a follow-on, including a 1.5 million share overallotment, on Jan. 22. Jefferies, Barclays Capital, Cantor Fitzgerald, Chardan...
19:11 , Nov 17, 2017 |  BC Week In Review  |  Financial News

Alnylam completes upsized $805M follow-on

On Nov. 16, Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) raised $805 million through the sale of 6.4 million shares at $125 in a bumped-up follow-on underwritten by Goldman Sachs, JPMorgan, Barclays, Credit Suisse, Piper Jaffray, JMP Securities,...
19:54 , Nov 14, 2017 |  BC Extra  |  Financial News

Alnylam raises $700M in follow-on

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) raised $700 million late Monday through the sale of 5.6 million shares at $125 in a bumped-up follow-on underwritten by Goldman Sachs, JPMorgan, Barclays, Credit Suisse, Piper Jaffray, JMP Securities, Needham,...